Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy ; volume:37 ; number:7 ; day:20 ; month:5 ; year:2020 ; pages:3163-3177 ; date:7.2020
Advances in therapy ; 37, Heft 7 (20.5.2020), 3163-3177, 7.2020
- Creator
-
Bowen, James
Mehta, Rina
Pelletier, Corey
Tian, Marc
Noxon, Virginia
Johnson, Barbara H.
Bonafede, Machaon
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-020-01367-1
- URN
-
urn:nbn:de:101:1-2020082101112140127530
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bowen, James
- Mehta, Rina
- Pelletier, Corey
- Tian, Marc
- Noxon, Virginia
- Johnson, Barbara H.
- Bonafede, Machaon
- SpringerLink (Online service)
Other Objects (12)
Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Current Disease-Modifying Therapies in Multiple Sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Current Disease-Modifying Therapies in Multiple Sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
Retrospective Claims Analysis of Treatment Patterns, Relapse, Utilization, and Cost Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Current Disease-Modifying Therapies in Multiple Sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Intracerebral haemorrhage in multiple sclerosis: assessing the impact of disease-modifying medications
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations